Healthcare -
Biotechnology - NASDAQ - US
$ 7.54
-5.16 %
$ 63.5 M
Market Cap
-0.54
P/E
Price Target
Average
--12.47%
Revenue Forecast
Estimate
29.99%
EBIT
Estimate
--30.61%
Net Income
Estimate
75.37%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Karyopharm Therapeutics Inc.
Wall Street analysts predict an average 1-year price target for KPTI of $6.6 , with forecasts ranging from
a
low of
$3 to a high of $14 .
KPTI Lowest Price Target
Wall Street Target
3 USD
-60.21%
KPTI Average Price Target
Wall Street Target
6.6 USD
-12.47%
KPTI Highest Price Target
Wall Street Target
14 USD
85.68%
REVENUE FORECAST
Revenue Forecast Chart KPTI
EBIT FORECAST
EBIT Forecast Chart KPTI
NET INCOME FORECAST
Net Income Chart KPTI